Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Nevro Corp (NVRO)
Nevro Corp (NVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 684,835
  • Shares Outstanding, K 36,120
  • Annual Sales, $ 406,370 K
  • Annual Income, $ 3,000 K
  • 60-Month Beta 0.88
  • Price/Sales 1.71
  • Price/Cash Flow N/A
  • Price/Book 2.39
Trade NVRO with:

Options Overview Details

View History
  • Implied Volatility 61.56% ( +7.79%)
  • Historical Volatility 28.58%
  • IV Percentile 46%
  • IV Rank 55.12%
  • IV High 91.86% on 09/08/23
  • IV Low 24.33% on 06/01/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 31
  • Volume Avg (30-Day) 273
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 10,245
  • Open Int (30-Day) 10,596

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.78
  • Number of Estimates 9
  • High Estimate -0.45
  • Low Estimate -0.92
  • Prior Year -0.62
  • Growth Rate Est. (year over year) -25.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.49 +1.95%
on 09/25/23
21.00 -10.24%
on 09/13/23
-0.52 (-2.68%)
since 08/25/23
3-Month
17.88 +5.43%
on 08/22/23
26.53 -28.95%
on 06/30/23
-6.11 (-24.48%)
since 06/26/23
52-Week
17.88 +5.43%
on 08/22/23
50.54 -62.70%
on 10/04/22
-25.98 (-57.95%)
since 09/26/22

Most Recent Stories

More News
New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 18.83 (-0.69%)
Nevro Announces Participation in Upcoming Investor Conferences

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...

NVRO : 18.83 (-0.69%)
Why Shares of Nevro Are Down Wednesday

The medical device maker saw increased revenue, but earnings lagged estimates.

NVRO : 18.83 (-0.69%)
Nevro: Q2 Earnings Snapshot

Nevro: Q2 Earnings Snapshot

NVRO : 18.83 (-0.69%)
Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 18.83 (-0.69%)
Nevro Announces Presentations at American Society of Pain & Neuroscience Fifth Annual Conference

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 18.83 (-0.69%)
Nevro to Present at the Canaccord Genuity 43rd Annual Growth Conference

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 18.83 (-0.69%)
Nevro to Report Second Quarter 2023 Financial Results

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 18.83 (-0.69%)
Nevro Announces Painful Diabetic Neuropathy Clinical Data Presentations at the American Diabetes Association 83rd Scientific Sessions

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 18.83 (-0.69%)
Nevro Names New Chief Commercial Officer

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 18.83 (-0.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation...

See More

Key Turning Points

3rd Resistance Point 20.07
2nd Resistance Point 19.66
1st Resistance Point 19.31
Last Price 18.83
1st Support Level 18.55
2nd Support Level 18.14
3rd Support Level 17.79

See More

52-Week High 50.54
Fibonacci 61.8% 38.06
Fibonacci 50% 34.21
Fibonacci 38.2% 30.36
Last Price 18.83
52-Week Low 17.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar